A business alliance that seems to symbolize the fast pace of the cannabis industry\u2019s globalization is wedding a Canadian cultivator with one of the world\u2019s largest drug and agro-chemical companies.<\/p>\n
The firm\u00a0Tilray<\/a>, one of the top Licensed Producers under the Canadian medical marijuana program, on March 18 announced that it has signed a binding \u201cletter of intent\u201d to form a \u201cstrategic partnership\u201d with\u00a0Sandoz Canada<\/a>, an arm of\u00a0Sandoz International GmbH<\/a>. The Switzerland-based giant is, in turn, a wing of\u00a0Novartis International<\/a>, the fourth-largest pharmaceutical company in the world by revenue.<\/p>\n Canada\u2019s\u00a0Financial Post reports<\/a> that the partnership will see co-branded products, joint research and development, and Sandoz Canada\u2019s sales department working to place non-smokable Tilray products in pharmacies and hospitals across the country \u2014 pending regulatory approval. The Financial Post hails the arrangement as \u201cthe first deal between a major pharmaceutical company and a Canadian cannabis producer.\u201d<\/p>\n Tilray, headquartered in the Vancouver port city of Nanaimo, is owned by Seattle cannabis-industry investment firm\u00a0Privateer Holdings<\/a>. In 2014, it became the tenth company to secure a license under\u00a0Health Canada<\/a>\u2018s\u00a0Access to Cannabis for Medical Purposes Regulations<\/a>.<\/p>\n Tilray is also the first company worldwide to legally export medical cannabis<\/a> into the European Union. It achieved this position after winning a Good Manufacturing Practice certification under\u00a0European Medicines Agency\u00a0standards in December 2016, as the In-Pharma trade publication noted<\/a>.<\/p>\n A Tilray press release<\/a> calls the pact with Sandoz a \u201cmajor milestone in the recognition of medical cannabis and cannabinoids as conventional medicine.\u201d<\/p>\n<\/blockquote>\n It boasts that Tilray \u201ccurrently supplies tens of thousands of patients with high-quality, cGMP-certified products in ten countries spanning five continents.\u201d<\/p>\n Tilray\u2019s global operations are expanding fast. Last year, it received a license to cultivate cannabis and process medications in Portugal. The company is hoping to begin operations in the Iberian peninsula country this year, according to a February\u00a0press release<\/a>. Tilray will now be cultivating at the\u00a0BIOCANT Research Park\u00a0in Portugal\u2019s coastal town of Cantanhede, as well as its own Vancouver Island facilities. An indoor laboratory and genetics bank is already complete at Tilray\u2019s BIOCANT center, with an expansive greenhouse under construction. Tilray products are now available in Germany, the Czech Republic, Croatia and other European countries.<\/p>\n Tilray also just became the first company to export medical cannabis products to South Africa \u201cfor nationwide distribution to qualified patients through pharmacies.\u201d A\u00a0press release<\/a>\u00a0from the company noted that this marks the first such exports to anywhere on the continent of Africa. In a partnership with South Africa\u2019s\u00a0BGM Pharmaceuticals<\/a>, Tilray is providing orally administered extracts, soon to be available in the country\u2019s pharmacies.<\/p>\n In general, Canada\u2019s Licensed Producers increasingly seem\u00a0poised to dominate<\/a>\u00a0the country\u2019s coming adult-use market, as well as the medical industry, after legalization takes effect this year.\u00a0For example, another Licensed Producer,\u00a0Cronos Group<\/a>\u00a0of Toronto, last month became the first corporate cannabis cultivator to be\u00a0listed on the NASDAQ<\/a>\u00a0stock exchange.<\/p>\n TELL US,<\/strong> do you think Canada\u2019s cannabis companies are going to dominate the marijuana market?<\/p>\n The post Top Canadian Pot Producer Wins Deal With Pharma Giant<\/a> appeared first on Cannabis Now<\/a>.<\/p>\n
A business alliance that seems to symbolize the fast pace of the cannabis industry\u2019s globalization is wedding a Canadian cultivator with one of the world\u2019s largest drug and agro-chemical companies. The firm\u00a0Tilray, one of the top Licensed Producers under the Canadian medical marijuana program, on March 18 announced that itContinue Reading<\/a><\/span><\/p>\n","protected":false},"author":190,"featured_media":0,"comment_status":"false","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[2284,34,50,170,139,3744,3705,1088],"tags":[],"_links":{"self":[{"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/posts\/24673"}],"collection":[{"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/users\/190"}],"replies":[{"embeddable":true,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/comments?post=24673"}],"version-history":[{"count":1,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/posts\/24673\/revisions"}],"predecessor-version":[{"id":24674,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/posts\/24673\/revisions\/24674"}],"wp:attachment":[{"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/media?parent=24673"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/categories?post=24673"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/tags?post=24673"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}\n
\n
\nRead More: Top Canadian Pot Producer Wins Deal With Pharma Giant<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"